No real capital yet. Forward-test on a demo/stress account until live Sharpe holds for 60+ days.
A classic RSI-2 mean-reversion strategy that buys when the 2-period RSI drops below 10 (oversold) and sells short when it rises above 90 (overbought). It is designed for short-term counter-trend trading and works best in range-bound or mildly trending markets where price tends to revert quickly.
| Metric | Original ★ | Improved +low_vol+flat |
|---|---|---|
| OOS Sharpe | 0.261 | 0.221 |
| Stress Sharpe (3x cost) | -0.405 | -0.570 |
| Ann return | 3.2% | 1.2% |
| Max drawdown | -17.7% | -11.8% |
| Ann turnover | 81.8 | 43.3 |
| PSR (P[Sharpe>0]) | 0.753 | 0.717 |
| Bootstrap p(mean<=0) | 0.166 | 0.248 |
Recommended: original — OOS Sharpe 0.261, PSR 0.753, bootstrap p 0.166.
| Asset | Sharpe | Stress |
|---|---|---|
| SPY | 0.26 | -0.41 |
| QQQ | 0.66 | 0.06 |
| IWM | 0.02 | -0.56 |
| EEM | -0.16 | -0.83 |
| EWZ | 0.16 | -0.26 |
| GLD | -0.27 | -1.36 |
| AAPL | 0.89 | 0.44 |
| MSFT | 1.17 | 0.68 |
| Timeframe | Sharpe | Stress |
|---|---|---|
| D | 0.26 | -0.41 |
| W | 0.05 | -0.06 |
| M | 0.54 | 0.52 |
Out-of-sample, net of cost. PSR / bootstrap / stress-test robustness is what a TradingView backtest cannot show. Not investment advice.